Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.
NCT ID: NCT07137234
Last Updated: 2025-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
32 participants
INTERVENTIONAL
2025-03-15
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Botulinum Toxin Injection in Reducing Lip Scar Following Cleft Lip Repair
NCT05559281
Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair
NCT02247193
Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars
NCT04756882
Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty
NCT03047499
Use of Botulinum Toxin A in Direct Eyebrow Lift Scar
NCT06465056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I : 16 patient with unilateral cleft lip treated with surgical procedure alone
Modified Millard rotation advancement flap technique
the cleft is repaired by surgical intervention
Group II : 16 patients with unilateral cleft lip treated with botulinum toxin injection and surgery
Modified Millard rotation advancement flap technique
the cleft is repaired by surgical intervention
botulinum toxin injection (BTX A) before surgical intervention
the patient will receive Botulinum toxin type A followed by surgical closure of cleft lip
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modified Millard rotation advancement flap technique
the cleft is repaired by surgical intervention
botulinum toxin injection (BTX A) before surgical intervention
the patient will receive Botulinum toxin type A followed by surgical closure of cleft lip
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. free from any systemic disease
Exclusion Criteria
10 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Basel Saeed Sayed Ahmed Shamaa
Clinical Demonstrator at oral and maxillofacial surgery department, Faculty of dentistry, Mansoura University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Basel Saeed Shamaa, Master's
Role: PRINCIPAL_INVESTIGATOR
Mansoura University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M0101025OS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.